合成生物学 ›› 2025, Vol. 6 ›› Issue (3): 701-714.DOI: 10.12211/2096-8280.2025-040

• 特约评述 • 上一篇    

生物制造标准体系建设的现状、问题与建议

黄怡1, 司同1, 陆安静2   

  1. 1.中国科学院深圳先进技术研究院,定量合成生物学全国重点实验室,深圳合成生物学创新研究院,广东 深圳 518055
    2.中国电子信息产业发展研究院,北京 100081
  • 收稿日期:2025-04-29 修回日期:2025-06-04 出版日期:2025-06-30 发布日期:2025-06-27
  • 通讯作者: 陆安静
  • 作者简介:黄怡(1996—),女,助理研究员。研究方向为生物制造科技情报分析与政策研究。E-mail:y.huang2@siat.ac.cn
    陆安静(1987—),男,副研究员。研究方向为生物制造产业分析、市场与政策研究。E-mail:legendblue@foxmail.com

Standardization for biomanufacturing: global landscape, critical challenges, and pathways forward

HUANG Yi1, SI Tong1, LU Anjing2   

  1. 1.State Key Laboratory of Quantitative Synthetic Biology,Shenzhen Institute of Synthetic Biology,Shenzhen Institutes of Advanced Technology,Chinese Academy of Sciences,Shenzhen 518055,Guangdong,China
    2.China Center for Information Industry Development,Beijing 100081,China
  • Received:2025-04-29 Revised:2025-06-04 Online:2025-06-30 Published:2025-06-27
  • Contact: LU Anjing

摘要:

生物制造作为全球科技革命与产业变革的战略制高点,正通过合成生物学和人工智能等前沿技术的深度融合和协同创新,驱动物质生产方式实现颠覆性重塑。生物制造领域的标准化工作是加速科学发现进程、大幅增进生产效能、确保产业健康发展的重要基础。全球主要经济体均已将生物制造标准化列为国家竞争核心要素,竞相争夺产业发展主导权。本文梳理了国内外生物制造领域标准建设现状,从技术研发、产业生态、国际协同三个维度识别出标准制定进程滞后、跨领域标准协同受阻、国际标准互认壁垒三大问题。基于此提出构建动态化标准转化机制、建立跨领域标准协同平台、实施标准国际化计划的标准体系协同发展路径,为我国加快建设生物制造标准体系、推动生物制造从“技术驱动”转向“标准主导”的发展阶段提供理论支撑和决策参考。

关键词: 合成生物学, 生物制造, 标准体系, 产业协同

Abstract:

Biomanufacturing represents a strategic frontier in the global technological revolution and industrial transformation, disruptively reshaping how we produce various products such as biofuels, bioenergy, biobased chemicals, and biomaterials through the convergence of synthetic biology, artificial intelligence, and other cutting-edge technologies. However, the persistent lack of comprehensive standardization frameworks in this emerging field poses significant challenges. Standardization in biomanufacturing is essential for accelerating scientific discovery, enhancing production efficiency, and ensuring sustainable industry growth. Therefore, major global economies have prioritized biomanufacturing standardization as a critical element of national competitiveness. The United States, through the National Institute of Standards and Technology (NIST), has established itself as a global leader in developing standards for data, metrology, intelligent algorithms, and automated facilities. NIST spearheads numerous ISO standards in biotechnology and biomanufacturing that shape international practices. In the United Kingdom, the Centre for Engineering Biology Metrology and Standards formulates roadmaps to guide the development of metrology and standards for engineering biological species. The European Union fosters the standards in metrology, chassis, yeast, and other eukaryotic systems through the International Cooperation for Synthetic Biology Standardization Project (BioRoBoost). The European Committee for Standardization has been particularly active in developing and updating standards for biomaterials and biobased products including wood-derived products, while establishing corresponding product classification rules. Since launching its 14th Five-Year Plan, China has strategically prioritized the development of standardization for biomanufacturing across the entire value chain, including key components such as sensors, production equipment like bioreactors, and operational processes such as production technical specifications. Furthermore, China has implemented a series of standards for product quality control, testing methods, and evaluation procedures across various biomanufacturing application sectors, including food, pharmaceuticals, fine chemicals, and others. This article presents a comprehensive assessment on the development of biomanufacturing standardization worldwide and in China. At the international level, we focus on standards issued by major international organizations in three major categories: basic commonalities, enabling technologies, and application fields. At the domestic level, our analysis is based on systematic data mining from China Standards Service Network. Our findings reveal several notable patterns. First, the distribution of standard types shows a clear hierarchical structure, with association standards comprising the majority, which highlights the pivotal role of professional organizations in driving technical integration and standardization. Second, we observed substantial variations in standardization maturity across application sectors. Biobased materials currently possess the most comprehensive portfolio with standards for standardization, followed by rapid progress in biobanking and active pharmaceutical ingredient manufacturing. Based on the current status, we identifies major challenges including the lagging of standard formulation, the obstruction of cross-disciplinary standard coordination, and the insufficiency of mutual recognition for international standards, through multi-dimensional analysis encompassing technological development, industrial ecosystem, and international collaboration. To address these challenges, we propose a strategic framework for developing biomanufacturing standards, including the construction of a dynamic standard transformation mechanism, the establishment of a cross-sector standard coordination platform, and the implementation of a standard internationalization plan. These recommendations provide both theoretical foundations and decision-making references for accelerating the development of biomanufacturing standardization system in China. By facilitating the transition from technology-driven to standard-led development in biomanufacturing, this framework aims to help secure China’s competitiveness in the global economy.

Key words: synthetic biology, biomanufacturing, standard framework, industrial collaboration

中图分类号: